Emily Pimblett
Vermogen: 207 012 $ op 31-05-2026
Vermogen: 207 012 $ op 31-05-2026
Emily Pimblett worked as Controller at Avvo, Inc. from 2017 to 2019.
Ms. Pimblett worked as Controller at DomainTools LLC from 2019 to 2021.
Ms. Pimblett worked as Chief Accounting Officer at Climb Bio, Inc. from 2023 to 2025.
Ms. Pimblett completed undergraduate and graduate degrees at the University of Washington.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CLIMB BIO, INC. 0,03% | 20-06-2025 | 18.888 ( 0,03% ) | 207 012 $ | 31-05-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
DomainTools LLC
DomainTools LLC Packaged SoftwareTechnology Services Develops threat intelligence and domain security platform for enterprises and governments | Comptroller/Controller/Auditor | 01-03-2021 |
Avvo, Inc.
Avvo, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an online legal directory | Comptroller/Controller/Auditor | 01-03-2019 |
| CLIMB BIO, INC. | Comptroller/Controller/Auditor | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avvo, Inc.
Avvo, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an online legal directory | Commercial Services |
DomainTools LLC
DomainTools LLC Packaged SoftwareTechnology Services Develops threat intelligence and domain security platform for enterprises and governments | Technology Services |
Eliem Therapeutics, Inc.
Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau